Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)

Market Cap	2.85B +23.9%
Revenue (ttm)	520.13M +1.3%
Net Income	-199.51M
EPS	-1.50
Shares Out	99.88M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,493,186
Open	29.42
Previous Close	29.15
Day's Range	28.46 - 29.68
52-Week Range	19.91 - 46.92
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About SHA:603139

Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical intermediates in China. It is involved in the research, development, production, and sale of traditional Chinese medicine preparations; research and development of prepared slices of Chinese medicinal herbs and pharmaceutical intermediates; and pharmaceutical distribution of biological products, blood products, pharmaceuticals, and traditional Chinese medicine. The company also provides products for the treatment of dermatologic...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 804
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603139

Financial Performance

In 2025, SHA:603139's revenue was 471.29 million, a decrease of -16.09% compared to the previous year's 561.63 million. Losses were -333.45 million, 272.1% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error